AB | BC | MB | NB | NL | NS | NT | ON | PE | QC | SK | YT

News & Announcements

2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008

July | June | May | Apr | Mar | Feb | Jan

Foreign Product Alert
July 07, 2016

Health Canada is advising Canadians not to use these foreign health products as they may pose a health risk. These products have been found by regulators in other countries to contain undeclared drug ingredients, toxic substances or high levels of heavy metals, which may pose serious health risks. Prescription drugs should only be taken under the supervision of a health care practitioner.

These products are not authorized for sale in Canada and have not been found on the Canadian market, but

[> More]

Health Product Infowatch
July 04, 2016

The June issue of the Health Product InfoWatch published by Health Canada is now available. This monthly publication provides clinically relevant safety information on pharmaceuticals, biologics, medical devices and natural health products. Please consult the index for a complete listing of previous issues.

Health Product Risk Communication
July 13, 2016

BLINCYTO (blinatumomab) and Pancreatitis - Amgen Canada Inc.

There have been reported cases of life-threatening, sometimes fatal pancreatitis associated with the use BLINCYTO (blinatumomab). The Canadian Product Monograph has been updated to reflect this new safety information. 

Health Canada Health Product Risk Communication

July 19, 2016

Alere Inc. initiating voluntary withdrawal of Alere INRatio® and INRatio® 2 PT/INR Monitoring System that may pose serious health risks

Alere Inc. is withdrawing the Alere INRatio® and INRatio®2 Prothrombin Time Monitoring Systems (professional and self-test)  devices from the Canadian market. These devices measure  blood clotting time in patients requiring warfarin and other oral blood-thinning medicines. There is a risk that the Alere devices provide an inaccurate low reading.

Health Canada Advisory